# clm_E4583C178C44

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 8,979,200,000 United States dollar  
valid_from: 2021-12-31  
valid_to: 2022-03-31  
published: 2022-02-23  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0575AF1A3F2A  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 8,979,200,000 United States dollar", as of 2021-12-31 (until 2022-03-31). Claim clm_E4583C178C44, https://asof.is/claim/clm_E4583C178C44, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947822000068/0000059478-22-000068-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-K FY2021, filed 2022-02-23  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947822000068/0000059478-22-000068-index.htm (primary, SEC EDGAR 10-K FY2021, published 2022-02-23)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 7,757,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_E4583C178C44](/claim/clm_E4583C178C44.md) | [clm_B6A71BBF205E](/claim/clm_B6A71BBF205E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
